• ML133 HCl for Kir2.1 Research

  2026-09-04

  ML133 HCl is a selective potassium channel inhibitor for separating Kir2.1-dependent signaling from broader potassium-channel effects. This practical guide adapts published pulmonary artery smooth muscle cell findings into concentration planning, pathway validation, migration assays, and troubleshooting workflows.

• 7-dehydro Cholesterol: Sterol Assay Workflows

  2026-09-04

  Use 7-dehydro Cholesterol to connect DHCR7 activity, cholesterol flux, UVB-driven vitamin D3 formation, and oxidative sterol biology in one experimental framework. This guide translates those principles into practical cell, skin-model, and comparative immune workflows, with formulation, dosing, and troubleshooting guidance.

• Localized BDNF Release in Early NMJ Assembly

  2026-09-03

  The reference study shows that muscle-derived BDNF is not released uniformly during neuromuscular junction development. Instead, BDNF is trafficked to podosome-like structures, proteolytically processed, and released in an activity- and calcium-dependent manner to organize early acetylcholine receptor clusters.

• Polygodial Workflows for TRPA1 Research

  2026-09-03

  Polygodial provides a practical chemical trigger for connecting TRPA1 activation with calcium influx, NFAT signaling, and epithelial inflammatory outputs. This workflow-oriented guide explains how to build concentration-controlled assays, separate channel engagement from downstream effects, and troubleshoot variable responses in sensory and airway models.

• AO/PI Staining Solution for Podocyte Assays

  2026-09-02

  Discover how AO/PI Staining Solution can strengthen diabetic nephropathy workflows by pairing fluorescence-based live/dead measurements with pathway-level evidence. This guide translates phillygenin research into a practical, limitation-aware assay strategy for accurate cell counting.

• Rucaparib in DNA Damage Response Research

  2026-09-02

  Rucaparib (AG-014699) is a potent PARP1 inhibitor for testing how impaired base excision repair, homologous recombination defects, and NHEJ suppression shape cancer-cell sensitivity. This workflow-focused guide covers stock preparation, radiosensitization assays, orthogonal DNA-damage readouts, and troubleshooting for reproducible cancer biology research.

• PPACK Dihydrochloride: From Thrombin to Thrombus

  2026-09-01

  PPACK Dihydrochloride offers translational researchers a high-affinity, irreversible way to isolate thrombin-dependent biology from platelet purinergic signaling. Paired with the NF449 reference study, it supports a more precise framework for interpreting thrombin inhibition assays, platelet aggregation inhibition, and blood coagulation research.

• Lopinavir: From HIV Potency to Assay Design

  2026-09-01

  Lopinavir and ABT-378 are examined through an assay-centered framework that connects HIV protease potency with cell-based antiviral interpretation. Learn how resistance controls, serum conditions, formulation, and cross-virus evidence shape rigorous HIV infection research.

• ZK53: Turning Mitochondrial Stress into Strategy

  2026-08-31

  ZK53 is a selective human mitochondrial serine protease ClpP activator that connects mitochondrial proteostasis, tumor-cell stress, DNA-damage signaling, and ferroptosis sensitivity.

• M344: Histone Deacetylase Inhibitor Guide

  2026-08-31

  M344 is a cell-permeable histone deacetylase inhibitor with a product-reported IC50 of 100 nM. It is a research tool for HDAC-mediated chromatin regulation, cancer-cell growth studies, differentiation experiments, radiation-response models, and HIV-1 latency research.

• Phillygenin Mechanisms in Diabetic Nephropathy

  2026-08-30

  A 2025 Phytomedicine study shows that phillygenin protects against diabetic nephropathy in high-glucose podocytes and db/db mice by coordinating suppression of TLR4/MyD88/NF-κB inflammation with support of PI3K/AKT/GSK3β signaling. The work links reduced cytokine production and apoptosis to improved albuminuria and renal injury, while also defining important limits for translating pathway-level findings into therapeutic practice.

• JAK Inhibitors and RA Sensory Neuron Activation

  2026-08-29

  This preprint identifies a direct effect of rheumatoid arthritis synovial fluid on human sensory neurons and shows that JAK inhibition can block associated STAT3 signaling and pain-relevant transcriptional responses. The findings provide a mechanistic hypothesis for the analgesic effects of JAK inhibitors, while also highlighting the value of combining patient-derived fluids, iPSC-derived neurons, transcriptomics, and functional neuronal assays.

• Ganetespib: From Hsp90 to Translational Strategy

  2026-08-28

  A mechanistic and strategic framework for using Ganetespib (STA-9090) in cancer research, integrating Hsp90 client-protein degradation, tumor growth inhibition, assay design, and carefully bounded insights from NINJ1-mediated viral protein secretion.

• Z-VEID-FMK Workflow for Caspase-6 Studies

  2026-08-28

  Z-VEID-FMK offers a cell-permeable, irreversible way to test whether caspase-6 drives apoptotic substrate cleavage, rather than merely correlating with cell death. This workflow translates that mechanism into practical designs for neuronal apoptosis research, immune-cell models, and exploratory antiviral experiments involving the DDX23–SVA axis.

• Thymoquinone Workflows for Cardiotoxicity

  2026-08-27

  Build a practical thymoquinone workflow for modeling doxorubicin-induced cardiac injury with matched redox, ferroptosis, mitochondrial, and functional readouts. The approach translates a mouse cardioprotection study into formulation guidance, assay controls, and troubleshooting decisions for cell and preclinical research.

8122 records 1/542 page Next 12345 下5页 Last page